Pulse Biosciences, Inc. reported raising $50 Million in an initial SEC Form D filing, from an offering of $50 Million
Amount Raised
$50 Million
Round Type
Venture
HaywardBiotechnologyHealth CareMedicalTherapeuticsWho else raised in Medical and Therapeutics around the same time
Companies in the same sectors as Pulse Biosciences, Inc. that raised within 45 days of this round, from Fundz verified event records.
- OncoNano Medicine raised $50M (Series B) on June 17, 2021.
- Penumbra raised $2.7M (Seed) on August 23, 2021.
- ADARx Pharmaceuticals, Inc. raised $75M on August 17, 2021.
- GentiBio raised $157M (Series A) on August 11, 2021.
- Renovacor, Inc. raised $2.5M (Seed) on August 4, 2021.
- Edwards Lifesciences raised $100K (Pre-Seed) on July 27, 2021.
Who to call at Pulse Biosciences, Inc., and when
A new round usually means Pulse Biosciences, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Pulse Biosciences, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Pulse Biosciences, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Pulse Biosciences, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Pulse Biosciences, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Pulse Biosciences, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.